IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Asston Pharmaceuticals IPO is a Book Building listing on BSE SME exchange, with an ipo size of ₹ 27.56 Cr. The company is based in Mumbai and caters to Pharmaceutical sector. Sobhagya Capital Options is the merchant banker of Asston Pharmaceuticals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 16th January 2025.
Asston Pharmaceuticals IPO posted revenues of ₹ 37.08 Cr. and PAT of ₹ 7.92 Cr. in FY26 on annualised basis.
Revenue:
₹ 37.08 Cr.
EBITDA Margin:
31.39
% 
Net Worth: ₹ 12.04 Cr.
Market Capitalisation:
₹ 104.70 Cr.
P/E:
13.20 times
P/BV: 2.64 times
EV/EBITDA: 9.66 times
Financial results of Asston Pharmaceuticals IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | May-25 | FY25 | FY24 | FY23 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 31.83 | 28.12 | 20.26 | 13.69 | |
| Net Worth | 12.04 | 10.71 | 6.39 | 1.99 | |
| Total Debt | 7.98 | 7.25 | 6.82 | 5.25 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
6.18
37.08 |
25.03 | 15.59 | 6.54 | |
EBITDA
EBITDA on annualised basis |
1.94
11.64 |
6.71 | 2.55 | 1.52 | |
PAT
PAT on annualised basis |
1.32
7.92 |
4.32 | 1.36 | 1.06 | |
Asston Pharmaceuticals IPO PAT Margin is 21.36 % , ROCE (Return on Capital Employed) is 79.46 % as per latest financial. The below table shows Asston Pharmaceuticals IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | May-25 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| EBITDA Margin (%) | 31.39 | 26.81 | 16.36 | 23.24 |
| PAT Margin (%) | 21.36 | 17.26 | 8.72 | 16.21 |
| EPS (₹) | 2.11 | 6.90 | 2.37 | 1.89 |
| ROE (%) | 10.96 | 40.34 | 21.28 | 53.27 |
| ROCE (%) | 79.46 | 51.25 | 34.29 | 56.08 |
| ROA (%) | 4.15 | 15.36 | 6.71 | 7.74 |
| Debt to Equity | 0.66 | 0.68 | 1.07 | 2.64 |
The market Capitalisation of Asston Pharmaceuticals IPO is ₹ 104.70 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Asston Pharmaceuticals IPO prospectus highlights an Return on Equity (ROE) of 10.96 % , Return on Assets (ROA) of 4.15 %, and an EBITDA Margin of 31.39 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Asston Pharmaceuticals IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Asston Pharmaceuticals IPO is ₹ 104.70 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Asston Pharmaceuticals IPO has a Price-to-Earnings (PE) ratio of 13.20 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Asston Pharmaceuticals IPO reported revenue of ₹ 37.08 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Asston Pharmaceuticals IPO provide insights into sales growth, market demand, and business scalability.
Asston Pharmaceuticals recorded an EBITDA of ₹ 11.64 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Asston Pharmaceuticals Profit After Tax (PAT) is ₹ 7.92 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 37.08 Cr.
EBITDA Margin:
31.39
%
Net Worth: ₹ 12.04 Cr.
Market Capitalisation:
104.70
P/E:
13.20 times
P/BV: 2.64 times
EV/EBITDA:
9.66
Asston Pharmaceuticals operates in Pharmaceutical and Manufacturing And Export Of Both Pharmaceutical Formulations And Nutraceutical Products. The Issue is listed on BSE SME in Jul, 2025. Asston Pharmaceuticals IPO size was 27.56 with Issue price of 123.00 .
Merchant Banker(s) of Asston Pharmaceuticals IPO: Sobhagya Capital Options Limited
Asston Pharmaceuticals IPO subscription was 186.55 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Asston Pharmaceuticals IPO listed at a listing price of 119.00 against the offer price of 123.00.
The current market price of Asston Pharmaceuticals is 120.00.
Why Us?
